EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us

ROI in R&D declines sharply in 2022

Projected pharmaceutical R&D return on investment has hit its lowest level for 13 years, according to a new report by Deloitte.

Spotlight: December 2022 - January 2023

GOLD looks back at some of the pharma industry’s recent news.

RSV drug nirsevimab chases FDA approval

A drug to treat infants with RSV is on its pathway to approval in the US following a successful Biologics License Application to the FDA.

Pharma's sustainability agenda centre stage in new ABPI report

Global action is required to ensure pharma’s commitments to reach Net Zero are realised, according to a new ABPI report.

Pfizer joins GSK in RSV success

Pfizer plans to file for approval for its RSV vaccine for infants by the end of 2022 after achieving positive Phase 3 results.

First RSV vaccine for older adults earns pivotal Phase 3 results

A first-in-class vaccine for respiratory syncytial virus has shown to be highly efficacious in a Phase III trial, GSK has announced.

Promising outlook for integrating young talent in pharma

Collaboration between the pharmaceutical industry and academia is on the rise, according to a recent survey from the ABPI.

Pfizer-BioNTech assemble with the Avengers in COVID booster drive

Pfizer and BioNTech collaborate with Marvel on a comic encouraging COVID-19 booster vaccinations in the US.